GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)

GE HealthCare Technologies (GEHC) has 5 years of Current Deferred Revenue data on file, last reported at $2.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 13.98% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 13.98% YoY), and the FY2025 full-year result was $2.1 billion, up 7.82% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $2.2 billion, up from $2.1 billion in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $2.7 billion in Q2 2025 and bottomed at $1.9 billion in Q1 2024.
• The 5-year median for Current Deferred Revenue is $2.0 billion (2023), against an average of $2.1 billion.
• The widest annual swing landed in 2023, when Current Deferred Revenue jumped 38.34%; it then retreated 25.92% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $1.9 billion in 2022, then soared by 38.34% to $2.6 billion in 2023, then declined by 25.92% to $1.9 billion in 2024, then advanced by 7.82% to $2.1 billion in 2025, then grew by 2.77% to $2.2 billion in 2026.
• The last three Current Deferred Revenue figures came in at $2.2 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.

Peer Comparison